Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Protara Therapeutics, Inc. - Common Stock (NQ: TARA )

5.390 +0.210 (+4.05%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,004,260
Open 5.120
Bid (Size) 5.150 (1)
Ask (Size) 5.390 (1)
Prev. Close 5.180
Today's Range 5.010 - 5.410
52wk Range 1.595 - 10.48
Shares Outstanding 11,235,731
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Each week, Benzinga’s Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and deserve attention. 
Via Benzinga
Why DocuSign Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
Via Benzinga

Performance

YTD
+156.67%
+156.67%
1 Month
+125.52%
+125.52%
3 Month
+185.19%
+185.19%
6 Month
+141.70%
+141.70%
1 Year
+194.54%
+194.54%

More News

Read More
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Crude Oil Edges Lower; US Initial Jobless Claims Increase
Via Benzinga
Exposures Fossil Fuels
Recap: Protara Therapeutics Q1 Earnings
Via Benzinga
Protara Therapeutics Releases Early Cut Data From Investigational Cell-Based Therapy For Bladder Cancer
Via Benzinga
Why Is Protara Therapeutics Stock Skyrocketing Over 100% On Thursday?
Via Benzinga
Dow Falls 50 Points; Kroger Posts Downbeat Sales
Via Benzinga
Topics Stocks
Exposures US Equities
TARA Stock Earnings: Protara Therapeutics Beats EPS for Q2 2024
Via InvestorPlace
TARA Stock Earnings: Protara Therapeutics Misses EPS for Q1 2024
Via InvestorPlace
Alphabet To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
Protara Therapeutics Shares Interim Data From Bladder Cancer Study, Raises $45M Via Equity
Via Benzinga
Exposures Product Safety
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
3 Stocks That Could Help You Retire on a Private Island
Via InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Protara Therapeutics: Q3 Earnings Insights
Via Benzinga
Insider Buying 2022: 15 Stocks to Bet On Despite the Bear Market
Via InvestorPlace
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Executives Buy Around $35M Of 4 Penny Stocks: Nextdoor, GreenLight Biosciences And More
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.